Serological Confirmation of Chagas' Disease by a Recombinant and Peptide Antigen Line Immunoassay: INNO-LIA Chagas

Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease

BACKGROUND Chagas disease is due to the parasite Trypanosoma cruzi, a protist disseminated by a Triatome vector. This disease is endemic to Latin America and considered by WHO as one of the 17 world's neglected diseases. In Europe and in North America, imported cases are also detected, due to migration of population outside of the endemic region. Diagnosis of T. cruzi infection is usually made ...

Advances in Serological Diagnosis of Chagas’ Disease by Using Recombinant Proteins

Screening and confirmation in chagas disease serology - a contribution.

Evaluation of the "Symbiosys" immunoassay for the serological diagnosis of Chagas disease.

For the laboratory diagnosis of Chagas disease several tests are commonly used. Sensitivity and specificity must always be taken into account, as well as the fact that these methods vary when we are dealing with an acute or chronic stage of the parasitosis. Also, it is important to remember that the initial stage of Trypanosoma cruzi infection is characterized by the presence of the parasite in...

Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.

Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi and is one of the most important endemic problems in Latin America. Lately, it has also become a health concern in the United States and Europe. Currently, a diagnosis of Chagas' disease and the screening of blood supplies for antiparasite antibodies are achieved by conventional serological tests that show substantial variati...